THE EFFECTIVENESS OF MEDICATION ADHERENCE INTERVENTIONS IN IMPROVING OUTCOMES FOR PATIENTS WITH CARDIOVASCULAR DISEASE
Main Article Content
Keywords
medication adherence, cardiovascular disease, meta-analysis, primary studies, characteristics
Abstract
Objective: This study aims to provide a comprehensive overview of the characteristics of primary studies included in medication adherence meta-analyses for patients with cardiovascular disease.
Methods: A systematic review of medication adherence meta-analyses was conducted, and primary studies meeting the inclusion criteria were identified. Data from these studies were extracted and analyzed to determine the key characteristics.
Results: A total of 10 primary studies were included in the analysis. The meta-analysis revealed that medication adherence interventions significantly improved medication adherence rates (pooled effect size 0.45, 95% confidence interval [CI] 0.37-0.53). Furthermore, these interventions demonstrated a positive impact on clinical outcomes, with significant improvements in blood pressure control (pooled effect size -8.21 mmHg, 95% CI -10.02 to -6.39) and cholesterol levels (pooled effect size -15.31 mg/dL, 95% CI -18.10 to -12.51). Moreover, a reduction in cardiovascular events (pooled effect size 0.65, 95% CI 0.50-0.85) and an improvement in quality of life indicators (pooled effect size 0.57, 95% CI 0.42-0.73) were observed in patients receiving medication adherence interventions.
Conclusion: The characteristics of primary studies included in medication adherence meta-analyses indicate substantial heterogeneity in sample sizes, attrition rates, participant demographics, intervention characteristics, and study durations. The findings highlight the diverse approaches employed in medication adherence interventions for patients with cardiovascular disease.
References
2. Hogervorst, Stijn, et al. "Scalability of Effective Adherence Interventions for Patients Using Cardiovascular Disease Medication: A Realist Synthesis-Inspired Systematic Review." British Journal of Clinical Pharmacology, https://doi.org/10.1111/bcp.15418.
3. Chen J, Tang Z, Chen Z, Wei Y, Liang H, Zhang X, Gao Z, Zhu H. MicroRNA-218-5p regulates inflammation response via targeting TLR4 in atherosclerosis. BMC Cardiovascular Disorders 2023;23(1)
4. Lin W, Chen Y, Lin S, Cao H, Chen Q. Parents’ understanding and attitudes toward the use of the WeChat platform for postoperative follow-up management of children with congenital heart disease. Journal of Cardiothoracic Surgery 2023;18(1)
5. Ogungbe, Oluwabunmi, et al. "Medication Adherence Interventions for Cardiovascular Disease in Low- and Middle-Income Countries: A Systematic Review." Patient Preference and Adherence, vol. 15, 2021, pp. 885-897, https://doi.org/10.2147/PPA.S296280.
6. Arshed, Muhammad, et al. "Effectiveness of MHealth Interventions in Medication Adherence among Patients with Cardiovascular Diseases: A Systematic Review." Diseases, vol. 11, no. 1, 2023, p. 41, https://doi.org/10.3390/diseases11010041.
7. Chase, Ana, et al. "The Effectiveness of Medication Adherence Interventions among Patients with Coronary Artery Disease: A Meta-Analysis." The Journal of Cardiovascular Nursing, vol. 31, no. 4, 2016, p. 357, https://doi.org/10.1097/JCN.0000000000000259.
8. Ni, Z.; Liu, C.; Wu, B.; Yang, Q.; Douglas, C.; Shaw, R.J. An mHealth intervention to improve medication adherence among patients with coronary heart disease in China: Development of an intervention. Int. J. Nurs. Sci. 2018, 5, 322–330
9. Morawski, K.; Ghazinouri, R.; Krumme, A.; Lauffenburger, J.C.; Lu, Z.; Durfee, E.; Oley, L.; Lee, J.; Mohta, N.; Haff, N.; et al. Association of a Smartphone Application With Medication Adherence and Blood Pressure Control: The MedISAFE-BP Randomized Clinical Trial. JAMA Intern. Med. 2018, 178, 802–809.
10. Ivers, N.M.; Schwalm, J.D.; Bouck, Z.; McCready, T.; Taljaard, M.; Grace, S.L.; Cunningham, J.; Bosiak, B.; Presseau, J.; Witteman, H.O.; et al. Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): Pragmatic randomised controlled trial. BMJ 2020, 369, m1731.
11. Gandapur, Y.; Kianoush, S.; Kelli, H.M.; Misra, S.; Urrea, B.; Blaha, M.J.; Graham, G.; Marvel, F.A.; Martin, S.S. The role of mHealth for improving medication adherence in patients with cardiovascular disease: A systematic review. Eur. Hear. J. Qual. Care Clin. Outcomes 2016, 2, 237–244.
12. Gandhi, S.; Chen, S.; Hong, L.; Sun, K.; Gong, E.; Li, C.; Yan, L.L.; Schwalm, J.-D. Effect of Mobile Health Interventions on the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis. Can. J. Cardiol. 2017, 33, 219–231.
13. Kini V, Ho PM. Interventions to improve medication adherence: a review. JAMA. 2018;320(23):2461–2473. doi: 10.1001/jama.2018.19271
14. Mariani J, Rosende A, De Abreu M, et al. Multicap to improve adherence after acute coronary syndromes: results of a randomized controlled clinical trial. Ther Adv Cardiovasc Dis. 2020;14:1753944720912071. doi: 10.1177/1753944720912071
15. Farazian F, Emami Moghadam Z, Heshmati Nabavi F, Behnam Vashani H. Effect of self-care education designed based on bandura’s self-efficacy model on patients with hypertension: a randomized clinical trial. EBCJ. 2019;9(2):44–52. doi: 10.22038/ebcj.2019.36466.1944
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Jassim Zaheen Shah
Consultant Cardiologist, Heart Hospital Qatar
Ezzedin Alataresh
Consultant Cardiologist, Heart Hospital Qatar
Shahid Imran
Consultant Cardiologist, Heart Hospital Qatar